NeuroBo Pharmaceuticals Inc (NRBO)
4.40
-0.20
(-4.35%)
USD |
NASDAQ |
May 21, 16:00
4.40
0.00 (0.00%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Net Income (Quarterly): -6.714M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.714M |
| December 31, 2023 | -5.314M |
| September 30, 2023 | -3.818M |
| June 30, 2023 | -0.734M |
| March 31, 2023 | -2.604M |
| December 31, 2022 | -4.676M |
| September 30, 2022 | -3.113M |
| June 30, 2022 | -3.303M |
| March 31, 2022 | -2.875M |
| December 31, 2021 | -4.578M |
| September 30, 2021 | -3.461M |
| June 30, 2021 | -3.921M |
| March 31, 2021 | -3.324M |
| December 31, 2020 | -19.51M |
| September 30, 2020 | -3.054M |
| June 30, 2020 | -2.384M |
| March 31, 2020 | -4.73M |
| December 31, 2019 | -13.33M |
| September 30, 2019 | -3.621M |
| Date | Value |
|---|---|
| June 30, 2019 | -1.901M |
| March 31, 2019 | -2.464M |
| December 31, 2018 | 4.452M |
| September 30, 2018 | -6.079M |
| June 30, 2018 | -6.678M |
| March 31, 2018 | -7.224M |
| December 31, 2017 | -6.746M |
| September 30, 2017 | -8.671M |
| June 30, 2017 | -10.50M |
| March 31, 2017 | -7.496M |
| December 31, 2016 | -7.214M |
| September 30, 2016 | -3.878M |
| June 30, 2016 | -1.391M |
| March 31, 2016 | -2.103M |
| December 31, 2015 | -2.57M |
| September 30, 2015 | -2.569M |
| June 30, 2015 | -1.611M |
| March 31, 2015 | -2.279M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-19.51M
Minimum
Dec 2020
-0.734M
Maximum
Jun 2023
-4.848M
Average
-3.541M
Median
Net Income (Quarterly) Benchmarks
| Eli Lilly and Co | 2.243B |
| SIGA Technologies Inc | 10.28M |
| Vanda Pharmaceuticals Inc | -4.146M |
| Tenon Medical Inc | -3.576M |
| NovaBay Pharmaceuticals Inc | -3.214M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 6.881M |
| EPS Diluted (Quarterly) | -1.32 |
| Enterprise Value | 6.580M |
| Earnings Yield | -73.18% |